Abbott Laboratories (ABT)
USD 127.09
(2.08%)
USD 127.09
(2.08%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 13.59 Billion USD | -12.07% |
| 2022 | 15.46 Billion USD | -15.27% |
| 2021 | 18.25 Billion USD | -6.06% |
| 2020 | 19.42 Billion USD | 11.56% |
| 2019 | 17.41 Billion USD | -10.04% |
| 2018 | 19.35 Billion USD | -28.85% |
| 2017 | 27.21 Billion USD | 31.57% |
| 2016 | 20.68 Billion USD | 252.26% |
| 2015 | 5.87 Billion USD | 72.27% |
| 2014 | 3.4 Billion USD | 0.59% |
| 2013 | 3.38 Billion USD | -81.27% |
| 2012 | 18.08 Billion USD | 50.21% |
| 2011 | 12.03 Billion USD | -3.86% |
| 2010 | 12.52 Billion USD | 11.16% |
| 2009 | 11.26 Billion USD | 29.3% |
| 2008 | 8.71 Billion USD | -8.16% |
| 2007 | 9.48 Billion USD | 35.35% |
| 2006 | 7 Billion USD | 53.33% |
| 2005 | 4.57 Billion USD | -4.52% |
| 2004 | 4.78 Billion USD | 38.69% |
| 2003 | 3.45 Billion USD | -19.22% |
| 2002 | 4.27 Billion USD | -1.42% |
| 2001 | 4.33 Billion USD | 302.79% |
| 2000 | 1.07 Billion USD | -19.48% |
| 1999 | 1.33 Billion USD | -0.22% |
| 1998 | 1.33 Billion USD | 42.83% |
| 1997 | 937.98 Million USD | 0.55% |
| 1996 | 932.89 Million USD | 114.36% |
| 1995 | 435.19 Million USD | 51.59% |
| 1994 | 287.09 Million USD | -6.44% |
| 1993 | 306.84 Million USD | 178.95% |
| 1992 | 110 Million USD | -12.07% |
| 1991 | 125.1 Million USD | -7.2% |
| 1990 | 134.8 Million USD | -8.11% |
| 1989 | 146.7 Million USD | -58.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - USD | -2.39% |
| 2024 Q1 | 12.57 Billion USD | -7.52% |
| 2024 Q2 | 13.13 Billion USD | 4.48% |
| 2023 Q1 | 14.52 Billion USD | -6.1% |
| 2023 Q3 | 14.47 Billion USD | -0.58% |
| 2023 Q2 | 14.56 Billion USD | 0.28% |
| 2023 FY | 13.59 Billion USD | -12.07% |
| 2023 Q4 | 13.59 Billion USD | -6.06% |
| 2022 Q4 | 15.46 Billion USD | 1.1% |
| 2022 Q3 | 15.29 Billion USD | -8.7% |
| 2022 Q2 | 16.75 Billion USD | -1.94% |
| 2022 Q1 | 17.08 Billion USD | -6.39% |
| 2022 FY | 15.46 Billion USD | -15.27% |
| 2021 Q2 | 17.54 Billion USD | 0.33% |
| 2021 Q1 | 17.48 Billion USD | -9.99% |
| 2021 Q3 | 17.44 Billion USD | -0.58% |
| 2021 Q4 | 18.25 Billion USD | 4.62% |
| 2021 FY | 18.25 Billion USD | -6.06% |
| 2020 Q3 | 18.34 Billion USD | 0.91% |
| 2020 FY | 19.42 Billion USD | 11.56% |
| 2020 Q4 | 19.42 Billion USD | 5.89% |
| 2020 Q1 | 16.8 Billion USD | 0.86% |
| 2020 Q2 | 18.18 Billion USD | 8.21% |
| 2019 FY | 17.41 Billion USD | -10.04% |
| 2019 Q1 | 18.84 Billion USD | -2.66% |
| 2019 Q2 | 18.98 Billion USD | 0.73% |
| 2019 Q3 | 17.63 Billion USD | -7.08% |
| 2019 Q4 | 16.66 Billion USD | -5.54% |
| 2018 Q4 | 19.35 Billion USD | 0.39% |
| 2018 Q3 | 19.28 Billion USD | -2.72% |
| 2018 Q2 | 19.82 Billion USD | -6.29% |
| 2018 Q1 | 21.15 Billion USD | -22.26% |
| 2018 FY | 19.35 Billion USD | -28.85% |
| 2017 Q1 | 23.76 Billion USD | 14.91% |
| 2017 FY | 27.21 Billion USD | 31.57% |
| 2017 Q4 | 27.21 Billion USD | 16.73% |
| 2017 Q3 | 23.31 Billion USD | -2.1% |
| 2017 Q2 | 23.81 Billion USD | 0.19% |
| 2016 Q2 | 6.01 Billion USD | 0.65% |
| 2016 Q1 | 5.97 Billion USD | 1.81% |
| 2016 Q4 | 20.68 Billion USD | 246.13% |
| 2016 Q3 | 5.97 Billion USD | -0.68% |
| 2016 FY | 20.68 Billion USD | 252.26% |
| 2015 Q4 | 5.87 Billion USD | -1.38% |
| 2015 FY | 5.87 Billion USD | 72.27% |
| 2015 Q1 | 5.93 Billion USD | 74.03% |
| 2015 Q2 | 5.86 Billion USD | -1.16% |
| 2015 Q3 | 5.95 Billion USD | 1.55% |
| 2014 Q3 | 3.71 Billion USD | 9.29% |
| 2014 Q2 | 3.4 Billion USD | 0.47% |
| 2014 FY | 3.4 Billion USD | 0.59% |
| 2014 Q4 | 3.4 Billion USD | -8.36% |
| 2014 Q1 | 3.38 Billion USD | -0.03% |
| 2013 Q1 | 3.46 Billion USD | -80.83% |
| 2013 Q4 | 3.38 Billion USD | -0.44% |
| 2013 FY | 3.38 Billion USD | -81.27% |
| 2013 Q3 | 3.4 Billion USD | -0.23% |
| 2013 Q2 | 3.41 Billion USD | -1.61% |
| 2012 FY | 18.08 Billion USD | 50.21% |
| 2012 Q4 | 18.08 Billion USD | 50.03% |
| 2012 Q3 | 12.05 Billion USD | 0.42% |
| 2012 Q2 | 12 Billion USD | 1.2% |
| 2012 Q1 | 11.86 Billion USD | -1.48% |
| 2011 Q3 | 13.09 Billion USD | 3.71% |
| 2011 Q4 | 12.03 Billion USD | -8.07% |
| 2011 Q2 | 12.62 Billion USD | 0.78% |
| 2011 Q1 | 12.53 Billion USD | 0.05% |
| 2011 FY | 12.03 Billion USD | -3.86% |
| 2010 Q4 | 12.52 Billion USD | -3.0% |
| 2010 Q2 | 12.61 Billion USD | 15.94% |
| 2010 FY | 12.52 Billion USD | 11.16% |
| 2010 Q1 | 10.87 Billion USD | -3.44% |
| 2010 Q3 | 12.91 Billion USD | 2.36% |
| 2009 Q2 | 11.37 Billion USD | -2.61% |
| 2009 Q1 | 11.67 Billion USD | 34.0% |
| 2009 FY | 11.26 Billion USD | 29.3% |
| 2009 Q3 | 11.57 Billion USD | 1.8% |
| 2009 Q4 | 11.26 Billion USD | -2.68% |
| 2008 Q1 | 9.04 Billion USD | -4.69% |
| 2008 Q2 | 8.45 Billion USD | -6.46% |
| 2008 Q4 | 8.71 Billion USD | -5.96% |
| 2008 FY | 8.71 Billion USD | -8.16% |
| 2008 Q3 | 9.26 Billion USD | 9.54% |
| 2007 FY | 9.48 Billion USD | 35.35% |
| 2007 Q3 | 6.47 Billion USD | -1.94% |
| 2007 Q1 | 6.54 Billion USD | -6.68% |
| 2007 Q2 | 6.6 Billion USD | 0.99% |
| 2007 Q4 | 9.48 Billion USD | 46.46% |
| 2006 Q1 | 4.15 Billion USD | -9.18% |
| 2006 Q4 | 7 Billion USD | -6.64% |
| 2006 Q2 | 8.17 Billion USD | 96.9% |
| 2006 FY | 7 Billion USD | 53.33% |
| 2006 Q3 | 7.5 Billion USD | -8.15% |
| 2005 Q4 | 4.57 Billion USD | 49.93% |
| 2005 FY | 4.57 Billion USD | -4.52% |
| 2005 Q3 | 3.04 Billion USD | -35.4% |
| 2005 Q2 | 4.72 Billion USD | 0.47% |
| 2005 Q1 | 4.69 Billion USD | -1.88% |
| 2004 Q4 | 4.78 Billion USD | 1.26% |
| 2004 FY | 4.78 Billion USD | 38.69% |
| 2004 Q1 | 4.95 Billion USD | 43.59% |
| 2004 Q2 | 4.68 Billion USD | -5.46% |
| 2004 Q3 | 4.72 Billion USD | 0.89% |
| 2003 Q1 | 4.26 Billion USD | -0.1% |
| 2003 Q2 | 4.31 Billion USD | 1.09% |
| 2003 Q3 | 3.9 Billion USD | -9.45% |
| 2003 Q4 | 3.45 Billion USD | -11.67% |
| 2003 FY | 3.45 Billion USD | -19.22% |
| 2002 Q1 | 4.32 Billion USD | -0.26% |
| 2002 Q4 | 4.27 Billion USD | -4.08% |
| 2002 Q3 | 4.45 Billion USD | 1.25% |
| 2002 FY | 4.27 Billion USD | -1.42% |
| 2002 Q2 | 4.4 Billion USD | 1.77% |
| 2001 FY | 4.33 Billion USD | 302.79% |
| 2001 Q4 | 4.33 Billion USD | 0.03% |
| 2001 Q3 | 4.33 Billion USD | 0.54% |
| 2001 Q2 | 4.31 Billion USD | 300.49% |
| 2001 Q1 | 1.07 Billion USD | 0.0% |
| 2000 Q2 | 1.32 Billion USD | -0.02% |
| 2000 FY | 1.07 Billion USD | -19.48% |
| 2000 Q3 | 1.07 Billion USD | -18.86% |
| 2000 Q4 | 1.07 Billion USD | 0.0% |
| 2000 Q1 | 1.32 Billion USD | -0.75% |
| 1999 Q1 | 1.33 Billion USD | -0.01% |
| 1999 Q2 | 1.33 Billion USD | -0.15% |
| 1999 Q3 | 1.33 Billion USD | -0.09% |
| 1999 Q4 | 1.33 Billion USD | 0.03% |
| 1999 FY | 1.33 Billion USD | -0.22% |
| 1998 Q2 | 1.14 Billion USD | 0.13% |
| 1998 Q3 | 1.34 Billion USD | 17.49% |
| 1998 FY | 1.33 Billion USD | 42.83% |
| 1998 Q4 | 1.33 Billion USD | -0.09% |
| 1998 Q1 | 1.13 Billion USD | 21.51% |
| 1997 FY | 937.98 Million USD | 0.55% |
| 1997 Q4 | 937.98 Million USD | -0.16% |
| 1997 Q1 | 931.22 Million USD | -0.18% |
| 1997 Q2 | 931.05 Million USD | -0.02% |
| 1997 Q3 | 939.48 Million USD | 0.91% |
| 1996 Q1 | 433.72 Million USD | -0.34% |
| 1996 Q3 | 682.16 Million USD | 57.39% |
| 1996 Q2 | 433.43 Million USD | -0.07% |
| 1996 Q4 | 932.89 Million USD | 36.76% |
| 1996 FY | 932.89 Million USD | 114.36% |
| 1995 Q1 | 285.54 Million USD | -0.54% |
| 1995 FY | 435.19 Million USD | 51.59% |
| 1995 Q2 | 435.73 Million USD | 52.59% |
| 1995 Q4 | 435.19 Million USD | -0.02% |
| 1995 Q3 | 435.29 Million USD | -0.1% |
| 1994 Q2 | 307.27 Million USD | 0.14% |
| 1994 Q1 | 306.85 Million USD | 0.0% |
| 1994 Q3 | 307.92 Million USD | 0.21% |
| 1994 Q4 | 287.09 Million USD | -6.76% |
| 1994 FY | 287.09 Million USD | -6.44% |
| 1993 Q1 | 108.4 Million USD | -1.45% |
| 1993 Q2 | 108.7 Million USD | 0.28% |
| 1993 Q3 | 108.5 Million USD | -0.18% |
| 1993 Q4 | 306.84 Million USD | 182.8% |
| 1993 FY | 306.84 Million USD | 178.95% |
| 1992 Q3 | 95.2 Million USD | -11.36% |
| 1992 Q1 | 122.8 Million USD | -1.84% |
| 1992 Q2 | 107.4 Million USD | -12.54% |
| 1992 Q4 | 110 Million USD | 15.55% |
| 1992 FY | 110 Million USD | -12.07% |
| 1991 Q1 | 133.2 Million USD | -1.19% |
| 1991 Q3 | 132.2 Million USD | -1.86% |
| 1991 Q4 | 125.1 Million USD | -5.37% |
| 1991 FY | 125.1 Million USD | -7.2% |
| 1991 Q2 | 134.7 Million USD | 1.13% |
| 1990 Q1 | 149.1 Million USD | 1.64% |
| 1990 Q3 | 137.1 Million USD | -0.8% |
| 1990 Q2 | 138.2 Million USD | -7.31% |
| 1990 FY | 134.8 Million USD | -8.11% |
| 1990 Q4 | 134.8 Million USD | -1.68% |
| 1989 Q4 | 146.7 Million USD | 0.0% |
| 1989 FY | 146.7 Million USD | -58.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Allurion Technologies Inc. | 2.3 Million USD | -589622.463% |
| Artivion, Inc. | 305.53 Million USD | -4350.94% |
| Avanos Medical, Inc. | 159.4 Million USD | -8431.368% |
| Butterfly Network, Inc. | 22.83 Million USD | -59453.317% |
| Butterfly Network, Inc. | 22.83 Million USD | -59453.317% |
| Bio-Rad Laboratories, Inc. | 1.18 Billion USD | -1043.3% |
| Boston Scientific Corporation | 8.96 Billion USD | -51.758% |
| CONMED Corporation | 971.48 Million USD | -1299.819% |
| Edwards Lifesciences Corporation | 670 Million USD | -1929.701% |
| Paragon 28, Inc. | 109.79 Million USD | -12285.359% |
| Glaukos Corporation | 383.73 Million USD | -3443.824% |
| Globus Medical, Inc. | 417.4 Million USD | -3158.026% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -54633.156% |
| Integer Holdings Corporation | 959.92 Million USD | -1316.673% |
| Medtronic plc | 23.87 Billion USD | 43.046% |
| Myomo, Inc. | 115.16 Thousand USD | -11808687.774% |
| Nevro Corp. | 211.47 Million USD | -6330.669% |
| Owlet, Inc. | 22 Thousand USD | -61813536.364% |
| Penumbra, Inc. | 220.9 Million USD | -6055.928% |
| Vicarious Surgical Inc. | 13.78 Million USD | -98550.707% |
| Smith & Nephew plc | 2.17 Billion USD | -525.241% |
| Sonendo, Inc. | 14.03 Million USD | -96793.481% |
| STERIS plc | 3.12 Billion USD | -335.843% |
| Stryker Corporation | 10.9 Billion USD | -24.75% |
| Vapotherm, Inc. | 109.97 Million USD | -12265.2% |
| Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | -179.361% |